This topic contains a solution. Click here to go to the answer

Author Question: The ratio of the between-groups variance estimate to the within-groups variance estimate is ... (Read 172 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
The ratio of the between-groups variance estimate to the within-groups variance estimate is indicated by
 
  a. the F value.
  b. the degrees of freedom.
  c. the sum of squares.
  d. eta.

Question 2

If the F value indicates that the between-groups variance is not significantly greater than the within-groups variance in an ANOVA, we can conclude that
 
  a. there is random error.
  b. the group means are from the same population.
  c. the null hypothesis that the differences between the groups are due only to chance can be rejected.
  d. there was an error in the calculation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

spencer.martell

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

a

Answer to Question 2

b




Melani1276

  • Member
  • Posts: 516
Reply 2 on: Jun 19, 2018
Thanks for the timely response, appreciate it


jamesnevil303

  • Member
  • Posts: 337
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library